Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-09-23

Clinical Trial Update: Effects of Dolutegravir Based Regimen on HIV-1 Reservoir and Immune Activation

View source ↗

Summary

This clinical trial update investigates the effects of a dolutegravir-based regimen on the HIV-1 reservoir and immune activation. The study is sponsored by Univ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dolutegravir (dolutegravir)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: HIV-1 Infection | Status: UNKNOWN